Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Postoperative Pain in Elderly
NCT07063108Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain, postoperative delirium (POD) and postoperative depression comparing Test group (esketamine) with Control group (placebo) (2 arms). Primary endpoint: Numeric Rating Scale Pain Score at 24 hours. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painpostoperative delirium (POD)postoperative depression
Beyond the preview
Go deeper on NCT07063108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07063108.